Schöffski P - Search Results

1

Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel.

Schöffski P, Weihkopf T, Ganser A. Schöffski P, et al. Anticancer Res. 1998 Nov-Dec;18(6B):4751-6. Anticancer Res. 1998. PMID: 9891552 Review.

2

Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.

Bokemeyer C, Harstrick A, Schmoll HJ, Köhne-Wömpner CH, Schöffski P, Poliwoda H. Bokemeyer C, et al. Among authors: schoffski p. Ann Oncol. 1992 Jun;3(6):487-8. doi: 10.1093/oxfordjournals.annonc.a058243. Ann Oncol. 1992. PMID: 1498067

3

Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC.

Smyth JF, Smith IE, Sessa C, Schoffski P, Wanders J, Franklin H, Kaye SB. Smyth JF, et al. Among authors: schoffski p. Eur J Cancer. 1994;30A(8):1058-60. doi: 10.1016/0959-8049(94)90455-3. Eur J Cancer. 1994. PMID: 7654428 Clinical Trial.

4

Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.

Schöffski P, Freund M, Wunder R, Petersen D, Köhne CH, Hecker H, Schubert U, Ganser A. Schöffski P, et al. BMJ. 1998 Aug 8;317(7155):379-84. doi: 10.1136/bmj.317.7155.379. BMJ. 1998. PMID: 9694753 Free PMC article. Clinical Trial.

5

Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.

Schöffski P, Catimel G, Planting AS, Droz JP, Verweij J, Schrijvers D, Gras L, Schrijvers A, Wanders J, Hanauske AR. Schöffski P, et al. Ann Oncol. 1999 Jan;10(1):119-22. doi: 10.1023/a:1008360323986. Ann Oncol. 1999. PMID: 10076732 Free article. Clinical Trial.

6

Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels.

Schöffski P, Tacke F, Ganser A, Trautwein C, Martin MU, Petersen D. Schöffski P, et al. Transfusion. 1999 Apr;39(4):429-31. doi: 10.1046/j.1537-2995.1999.39499235679.x. Transfusion. 1999. PMID: 10220273 No abstract available.

7

Endogenous serum levels of thrombopoietic cytokines in healthy whole-blood and platelet donors: implications for plateletpheresis.

Tacke F, Schöffski P, Trautwein C, Martin MU, Stangel W, Seifried E, Manns MP, Ganser A, Petersen D. Tacke F, et al. Among authors: schoffski p. Br J Haematol. 1999 May;105(2):511-3. doi: 10.1111/j.1365-2141.1999.01328.x. Br J Haematol. 1999. PMID: 10233430 Free article.

8

Complete response of a gastric primary after a short but toxic course of 'S-1' EORTC Early Clinical Studies Group.

Schöffski P, Chollet P, Ganser A, Wiese KH, Rambusch E, de Vries MJ, Hanauske A. Schöffski P, et al. Ann Oncol. 1999 Sep;10(9):1117-20. doi: 10.1023/a:1008364601010. Ann Oncol. 1999. PMID: 10572613 Free article.

9

Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours.

Schöffski P, Hagedorn T, Grünwald V, Paul H, Merkle K, Kowalski R, Ganser A. Schöffski P, et al. J Cancer Res Clin Oncol. 2000 Jan;126(1):41-7. doi: 10.1007/pl00008463. J Cancer Res Clin Oncol. 2000. PMID: 10641748 Clinical Trial.

10

Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration.

Schöffski P, Ganser A, Pascheberg U, Büsche G, Gaede B, Hertenstein B. Schöffski P, et al. Ann Hematol. 2000 Feb;79(2):95-8. doi: 10.1007/s002770050018. Ann Hematol. 2000. PMID: 10741923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters